Immunotherapy-induced vitiligo and demyelinating plaques: a case report suggesting a neurocutaneous mechanism
Neurol Sci
.
2026 Mar 20;47(4):351.
doi: 10.1007/s10072-026-08923-7.
Authors
Demet Ersivri
1
,
Eda Hayber
2
,
Ufuk Yazar
3
,
Ahmet Uyar
2
,
Yusuf Acıkgoz
3
Affiliations
1
Lokman Hekim University Ankara Hospital Dermatology Department, Andiçen Mah, Polatlı 2 Cd., İdil Sk., No:44, Sincan, Ankara, 06930, Turkey. demetersivri06@gmail.com.
2
Lokman Hekim University Ankara Hospital Dermatology Department, Andiçen Mah, Polatlı 2 Cd., İdil Sk., No:44, Sincan, Ankara, 06930, Turkey.
3
Lokman Hekim University Ankara Hospital Internal Medicine Department, Andiçen Mah, Polatlı 2 Cd., İdil Sk., No:44, Sincan, Ankara, 06930, Turkey.
PMID:
41857257
DOI:
10.1007/s10072-026-08923-7
No abstract available
Keywords:
Adverse effects; Immune checkpoint inhibitors; Immunotherapy.